This site uses cookies to bring you the best experience. Find out more
Skip to main content
↑

News

Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also follow us on LinkedIn  

Oxford Biomedica named as winner of The Oxford Science Park Innovation Award 2019

Oxford Biomedica named as winner of The Oxford Science Park Innovation Award 2019

18 Jun 2019

Leading gene therapy manufacturer recognised as part of Oxfordshire Business Awards Oxford, UK, June 18 2019 – Its work on life-changing treatments for serious diseases has earned Oxford Biomedica, a leading gene and cell therapy group, The Oxford Science Park Innovation Award 2019. Given as part of the Oxfordshire Business Awards, it recognises the company as the sole manufacturer of the gene therapy vector used in the ground-breaking... Read more

Academic entrepreneur Brian Bellhouse celebrated with naming of new building

Academic entrepreneur Brian Bellhouse celebrated with naming of new building

24 Apr 2019

Turf cutting for the Bellhouse Building to be performed by Lord & Lady Drayson today Oxford, UK, April 24 2019 –  The Oxford Science Park, one of the UK’s leading parks for science and technology companies, is pleased to announce that its newest building is to be named in recognition of the achievements of academic entrepreneur and Magdalen College Fellow Professor Brian Bellhouse. The turf-cutting ceremony for the Bellhouse... Read more

Blue Earth Diagnostics Announces Addition of Axumin® (fluciclovine (18F)) to EAU Guidelines for imaging in patients with biochemical recurrence in Prostate Cancer

Blue Earth Diagnostics Announces Addition of Axumin® (fluciclovine (18F)) to EAU Guidelines for imaging in patients with biochemical recurrence in Prostate Cancer

16 Apr 2019

Oxford, UK – April 16, 2019 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that Axumin (fluciclovine (18F)) has recently been added to the European Association of Urology (EAU) 2019 Clinical Practice Guidelines in Oncology for Prostate Cancer (PCa). The EAU PCa Guidelines assist clinicians in making informed decisions, taking into consideration the scientific data available and individual... Read more

Blue Earth Diagnostics celebrates five year anniversary

Blue Earth Diagnostics celebrates five year anniversary

06 Mar 2019

Oxford, UK – March 6, 2019 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, recently celebrated the company’s five year anniversary. During this time, Blue Earth Diagnostics has delivered five years of innovation and continued growth with a proven track record and depth of expertise in the rapid development and global commercialization of radiopharmaceuticals for cancer management. Blue Earth Diagnostics employs... Read more

Oxford Bus Company and the Oxford Science Park form partnership as part of joint drive to improve connectivity

Oxford Bus Company and the Oxford Science Park form partnership as part of joint drive to improve connectivity

05 Mar 2019

OXFORD BUS COMPANY AND THE OXFORD SCIENCE PARK FORM PARTNERSHIP AS PART OF JOINT DRIVE TO IMPROVE CONNECTIVITY Oxford, UK, March 5 2019 – Oxford Bus Company and The Oxford Science Park have formed a partnership to strengthen the PickMeUp on-demand minibus service in the Eastern Arc of the city. The Oxford Science Park has become a formal corporate partner of the innovative ride sharing service, providing annual investment to support... Read more

The Daubeny Project

Imaginative design, inspiring spaces.

450,000 sq ft of
premium lab space
completing 2026

Discover More